Humana Inc (HUM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Published : Dec-2017

No. of Pages : 103

order by fax Inquire before Buying request discount

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Humana Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Humana Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Humana Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Humana Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Humana Inc, Medical Devices Deals, 2011 to YTD 2017 10
Humana Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Humana Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Continucare Acquires Assets Of S.B.B. Medical Group 13
Metropolitan Health Networks Acquires Ladia & Ladia 14
Metcare Of Florida Acquires Dr. Suzann Leslie 15
Metropolitan Health Networks Acquires Medical Practice From Selma C. Delima 16
Venture Financing 17
Omada Health Raises USD48 Million in Series C Financing 17
Partnerships 19
Allergan Enters into Research Agreement with Humana 19
Humana Enters Into Research Agreement With Astellas For Health Care Delivery 20
Humana Enters Into Research Agreement With Novo Nordisk For Diabetes 21
Equity Offering 22
Metropolitan Health Files Registration Statement For Public Offering Of Securities For US$200 Million 22
Acquisition 23
Wal-Mart May Buy Humana for USD46 Billion 23
MJ Acquisition Acquires Concentra for USD1 Billion 24
Humana Acquires Your Home Advantage 26
Humana Acquires Svenska Specialistpsykiatrigruppen From Valedo Partners 27
Humana Acquires American Eldercare, Healthcare Services Provider 28
Humana Completes Acquisition Of Metropolitan Health Networks For US$850 Million 29
Metcare of Florida To Acquire Kanner, Shteiman, Provider Of Healthcare Services 31
Humana Completes Acquisition Of SeniorBridge Family Companies From Caltius Equity Partners 32
Metropolitan Health Completes Acquisition Of Continucare For US$416 Million 33
Humana Inc - Key Competitors 35
Humana Inc - Key Employees 36
Humana Inc - Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 43
Strategy And Business Planning 43
May 10, 2017: Humana Brings Value-Based Orthopedic Specialty Care to North Carolina and Virginia 43
May 18, 2016: Humana Brings Value-Based Orthopaedic Specialty Care Model to Tennessee, Expands in Ohio 44
Financial Announcements 45
Nov 08, 2017: Humana Reports Third Quarter 2017 Financial Results 45
Aug 02, 2017: Humana Reports Second Quarter 2017 Financial Results; Raises Full Year 2017 Guidance; Provides Update on Bonus Year 2018 Star Ratings 47
May 03, 2017: Humana Reports Detailed First Quarter Financial Results; Reaffirms Recent Full-Year 2017 EPS Guidance Increase 48
Apr 24, 2017: Humana Pre-announces First Quarter 2017 EPS and Revenues and Increases Full-year 2017 EPS Guidance 49
Feb 08, 2017: Humana Reports Fourth Quarter 2016 Financial Results 50
Nov 04, 2016: Humana Reports Third Quarter 2016 Financial Results 53
Aug 19, 2016: Humana announces financial results for interim period January-June 2016 60
Aug 03, 2016: Humana Reports Second Quarter 2016 Financial Results; Reaffirms Recent 2016 Financial Guidance Increase 64
Jul 21, 2016: Humana Increases Earnings Guidance 74
May 04, 2016: Humana Reports First Quarter 2016 Financial Results; Reaffirms 2016 Financial Guidance 76
Feb 10, 2016: Humana Reports Fourth Quarter 2015 Financial Results; Provides 2016 Financial Guidance 78
Corporate Communications 79
Nov 13, 2017: Humana Elects Karen DeSalvo, M.D., to Board of Directors 79
Aug 21, 2017: Humana appoints new member to board of directors 80
Jun 23, 2017: Humana Names Sam Deshpande Chief Risk Officer 81
Apr 27, 2016: Humana Research on Medication Adherence and Medicare Advantage Wins Prestigious Awards 82
Mar 10, 2016: Humana Named No. 1 U.S. Health Care Company in Leading National Assessment of Corporate Sustainability Efforts 83
Government and Public Interest 84
Jul 18, 2017: Humana Foundation Awards $735,000 to South Florida Nonprofits to Improve Health of Community 84
Jul 12, 2016: Humana Approved for $3.6 Million Research Funding Award by the Patient-Centered Outcomes Research Institute 86
Product News 87
Feb 02, 2017: Study Finds Omada Diabetes Prevention Program Resulted in 7.5% Weight Loss in Humana Medicare Advantage Population 87
Other Significant Developments 88
Oct 26, 2017: New Study Finds Healthy Days Valid Tool for Evaluating Population Health in Medicare Advantage Patients with Chronic Conditions 88
Oct 17, 2017: Humana Expands Medicare Advantage Offerings in New Hampshire 89
Dec 14, 2016: Humana Simplifies Clinical Quality Metrics to Ease Growing Reporting Demands Placed on Physicians 90
Nov 28, 2016: Humana to Add JSA Medical Group's New Primary Care Practices Designed Exclusively for Medicare Beneficiaries to Florida Medicare Advantage Plan Networks 91
Nov 07, 2016: Humana Adds Telemedicine Technology Benefit in Medicare Advantage Plans Available in Georgia and South Carolina 93
Oct 28, 2016: Humana to Add EliteHealth's New Primary Care Practices Designed Exclusively for Medicare Beneficiaries to South Florida Medicare Advantage Plan Networks 94
Oct 13, 2016: Humana to Add Iora Health's New Primary Care Practices Designed Exclusively for Medicare Beneficiaries to Medicare Advantage Plan Networks in Arizona, Colorado and Washington 96
Oct 12, 2016: Humana Comments on Medicare Star Quality Ratings and Raises 2016 Financial Guidance 97
Jun 16, 2016: Humana and Mount Sinai Health Partners Create Improved Care Model 99
May 05, 2016: Hennepin County Medical Center Partnering with Humana on Value-Based Care Initiative 100
Mar 10, 2016: Humana Launches Value-Based Orthopedic Specialty Care Model in Ohio 101
Mar 03, 2016: Humana, DeKalb Medical and DeKalb Physician Hospital Organization Now Offer Value-based Care to Commercial Members 102
Appendix 103
Methodology 103
About GlobalData 103
Contact Us 103
Disclaimer 103

List of Tables
Humana Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Humana Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Humana Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Humana Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Humana Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Humana Inc, Medical Devices Deals, 2011 to YTD 2017 10
Humana Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Continucare Acquires Assets Of S.B.B. Medical Group 13
Metropolitan Health Networks Acquires Ladia & Ladia 14
Metcare Of Florida Acquires Dr. Suzann Leslie 15
Metropolitan Health Networks Acquires Medical Practice From Selma C. Delima 16
Omada Health Raises USD48 Million in Series C Financing 17
Allergan Enters into Research Agreement with Humana 19
Humana Enters Into Research Agreement With Astellas For Health Care Delivery 20
Humana Enters Into Research Agreement With Novo Nordisk For Diabetes 21
Metropolitan Health Files Registration Statement For Public Offering Of Securities For US$200 Million 22
Wal-Mart May Buy Humana for USD46 Billion 23
MJ Acquisition Acquires Concentra for USD1 Billion 24
Humana Acquires Your Home Advantage 26
Humana Acquires Svenska Specialistpsykiatrigruppen From Valedo Partners 27
Humana Acquires American Eldercare, Healthcare Services Provider 28
Humana Completes Acquisition Of Metropolitan Health Networks For US$850 Million 29
Metcare of Florida To Acquire Kanner, Shteiman, Provider Of Healthcare Services 31
Humana Completes Acquisition Of SeniorBridge Family Companies From Caltius Equity Partners 32
Metropolitan Health Completes Acquisition Of Continucare For US$416 Million 33
Humana Inc, Key Competitors 35
Humana Inc, Key Employees 36
Humana Inc, Other Locations 37
Humana Inc, Subsidiaries 40

List of Figures
Humana Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Humana Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Humana Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Humana Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Humana Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Humana Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
Humana Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Humana Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Humana Inc, Medical Devices Deals, 2011 to YTD 2017 10

Filed in: Pharmaceutical

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027 “The ambulatory EHR market is projected to grow at a CAGR of 6.1% between 2022 and 2027.” The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period. Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery. However, the interoperability issues & data security concerns are some of the challenges that are expected to limit the growth of the market to a certain extent during the forecast period. “Cloud-based was the fastest-growing segment in the delivery mode of ambulatory EHR market in 2021” Cloud-based segment is projected to growth at the hi......	$4950
Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027 “The pharmaceutical excipients market growth can be attributed to factors such as the rising pharmaceuticals market, advancements in functional excipients, and the growing generics market. The rapidly growing biopharmaceuticals sector will also influence market growth..” The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of 5.9% during the forecast period.The growth can be attributed to the expanding pharmaceutical industry which has fueled the drug production thereby increasing consumption rate for excipients. Additionally, factors like functional excipients development and upsurge in generics market is also likely to propel market growth. “The fillers & diluents functionality accounted for the larges......	$
Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027 “Digital Pharmacy market to register a CAGR of 17.0% during the forecasts period The digital pharmacy market is expected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the growing consumer preference toward buying online medicines during and post COVID-19 pandemic, consolidation in the market and partnerships, and increasing geriatric population. However, patients relying on pharmacists for clinical support and increasing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period. “Over-the-counter (OTC) products segment is estimated to grow at the highest rate during the forecast period” On the basis ofdrug type, t......	$4950
Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027 The pharmacy automation market is expected to grow at a CAGR of 7.9% in the forecast period. The pharmacy automation market is projected to reach USD 8.2 billion by 2027 from USD 5.6 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth in this market is attributed to the growing need to minimize medication errors, rapid decentralization of pharmacies, and growing focus on automation to reduce labor costs. However, the stringent regulations that delay product launches can inhibit the growth of this market. Based on product, the automated medication dispensing and storage systems segment holds the largest market share in 2021 Based on products, the pharmacy automation market is segmented into automated medication dispensing and storage systems, automated packagi......	$4950
Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027 The topical drug delivery market is expected to grow at a CAGR of 8.9% in the forecast period. The global topical drug delivery market is projected to reach USD 317.8 billion by 2027 from USD 207.4 billion in 2022, at a CAGR of 8.9%. The growth of this market can largely be attributed to the high prevalence of topical prescription therapy for dry eye diseases, growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, increase in prevalence of central nervous disorders, rising preference for non-invasive drug delivery methods. “The semi-solid formulation segment accounted for the largest share of the topical drug delivery market, based on product in 2021.” Based on products, the topical drug delivery the market is segmented into ......	$4950
Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026 “Increasing incidence and prevalence of neurological disorders is a key factors driving growth in the cognition and memory enhancement market’’ The global cognition and memory enhancement market is projected to reach USD 38.9 billion by 2026 from USD 23.4 billion in 2021, at a CAGR of 10.7% during the forecast period. Elevating prevalence of neurological disorders, such as dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuroinfections, stroke, and cerebral palsy, have increased significantly over the years. “By product & service segment, the cognition & memory-enhancing drugs segment has registered fastest growth rate during the forecast period” Based on product & service, the cognition and memory en......	$4950
High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027 The HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others. “The innovative HPAPIs segment is expected to account for the largest share of the market in 2021” Based on type, the HPAPI market is segmented into innovative and generic. The innovative segment is expected to account for the largest share of the HPAPI market in 2021. The large share can be attributed to the increased R&D investments. “The Synthetic APIs segment to account for the largest share of the market in 2021” Based on type of synthesis, the market is segmented into synthetic and biotech HPAPIs. The synthetic AP......	$4950
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027 “Increased risk of communicable diseases, Rising prevalence of bleeding disorders in global population, Use of Immunoglobulin’s for a range of neurological conditions, including multiple sclerosis, neuropathic pain, and chronic fatigue syndrome is expected to drive the overall growth of the plasma fractionation market.” The global plasma fractionation market size is projected to reach USD 36.7 billion by 2027 from USD 26.5 billion in 2022, at a CAGR of 6.7% during the forecast period. Market growth is driven mainly by factors such as rapid growth of geriatric population, growing prevalence of respiratory disorders such as alpha-1-antitrypsin deficiency (AATD) and emphysema, and use of plasma fractionation products as first-line therapies for a number of bleeding, hematological, an......	$4950
Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027 “Patient engagement solutions market to register a CAGR of 10.0% from 2022 to 2027” The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps. However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period. “Services segment is expected to grow at the highest rate......	$4950
Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027 The global Healthcare cloud computing market is projected to reach USD 89.4 billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%. The factors driving the market are adoption of technologies like telehealth, EHR, big data analytics, IoT, cloud computing, m health, wearlable devices, etc. “The healthcare provider solution was the largest segment in the healthcare cloud computing market in 2021.” The healthcare provider segment accounted for the larger share of 79.2% of the healthcare cloud computing market in 2021. The growing adoption of various health IT solutions such as EHR, e-prescribing, telehealth, mHealth, and others due to COVID-19 is one of the key factors contributing to the growth of this segment. “Among end users, the healthcare providers segment ac......	$4950

Humana Inc (HUM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027

Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027

Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027

Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027

Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026

High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027

Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027

Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027